REDHILL BIOPHARMA LTD-SP ADR (RDHL) Stock Balance Sheet
NASDAQ:RDHL - Nasdaq - US7574683014 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.88M | 5.57M | 13.30M | 28.90M | 14.30M | |||
| Marketable Securities | 2.73M | 0.00 | 6.70M | 9.10M | 15.50M | |||
| Receivables | 2.54M | 2.59M | 34.50M | 31.70M | 28.70M | |||
| Inventories | 3.65M | 4.39M | 11.00M | 14.80M | 6.50M | |||
| Other Current Assets | 1.10M | 3.59M | 20.40M | 4.70M | 5.50M | |||
| Total Current Assets | 11.91M | 16.14M | 85.90M | 89.20M | 70.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 437.00K | 1.18M | 7.20M | 4.20M | 5.70M | |||
| Intangibles | 5.55M | 5.58M | 65.60M | 71.60M | 87.90M | |||
| Other Non-Current Assets | 148.00K | 147.00K | 200.00K | 16.20M | 16.20M | |||
| Total Non-Current Assets | 6.13M | 6.91M | 73.00M | 92.00M | 109.70M | |||
| TOTAL ASSETS | 18.04M | 23.05M | 158.90M | 181.20M | 180.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 353.00K | 718.00K | 116.20M | 1.60M | 1.70M | |||
| Accrued Expenses | 9.99M | 4.59M | 17.90M | 20.90M | 24.10M | |||
| Accounts Payable | 1.17M | 3.28M | 15.40M | 28.20M | 29.10M | |||
| Other Current Liabilities | 10.71M | 10.65M | 47.90M | 30.70M | 18.30M | |||
| Total Current Liabilities | 22.22M | 19.24M | 197.50M | 81.50M | 73.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.00K | 455.00K | 6.40M | 86.20M | 85.20M | |||
| Other Non-Current Liabilities | 500.00K | 1.28M | 3.40M | 4.60M | 7.90M | |||
| Total Non-Current Liabilities | 503.00K | 1.74M | 9.80M | 90.80M | 93.20M | |||
| TOTAL LIABILITIES | 22.73M | 20.98M | 207.30M | 172.30M | 166.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -414.80M | -407.74M | -433.90M | -367.90M | -280.30M | |||
| Additional Paid In Capital | 375.08M | 388.36M | 382.60M | 375.20M | 293.10M | |||
| Common Shares | 35.04M | 21.44M | 2.80M | 1.50M | 1.10M | |||
| Shares Outstanding | 2.40M | 1.46M | 173.32K | 97.45K | 714.07K | |||
| Tangible Book Value per Share | -0.00 | -0.00 | -0.12 | -0.12 | -0.02 | |||
| Total Shareholders' Equity | -4.68M | 2.07M | -48.40M | 8.90M | 13.90M | |||
| TOTAL LIABILITIES AND EQUITY | 18.04M | 23.05M | 158.90M | 181.20M | 180.20M | |||
| Statistics | ||||||||
| Debt/Equity | -0.00 | 0.22 | -0.13 | 9.69 | 6.13 | |||
| Current Ratio | 0.54 | 0.84 | 0.43 | 1.09 | 0.96 | |||
| Return On Assets (ROA) | -45.82% | 103.77% | -45.10% | -53.94% | -42.27% | |||
| Return On Equity (ROE) | N/A | 1155.92% | N/A | -1098.20% | -547.99% | |||
| Return On Invested Capital (ROIC) | N/A | 262.27% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 262.27% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21